Burt E Anderson

Title: Burt E Anderson: Innovator in the Field of Antibacterial Treatments

Introduction

Burt E Anderson, an accomplished inventor based in Valrico, Florida, has made significant contributions to the field of microbiology through his innovative research and developments. With a portfolio of ten patents to his name, his work primarily focuses on the therapeutic applications of ciprofloxacin derivatives against various bacterial pathogens.

Latest Patents

Anderson's latest patents exemplify his commitment to advancing medical science. One notable invention involves the "Activity of new N-acylated ciprofloxacin derivatives against facultative intracellular bacteria." This research addresses the needs of combating facultative intracellular pathogens that cause diseases in both animals and humans. A selection of N-acyl ciprofloxacin analogues, synthesized from ciprofloxacin, was tested in vitro against several bacterial species to identify effective therapeutic alternatives. The results revealed that seven of the tested compounds, labeled RC4-125, RC4-143, RC4-147, RC5-28, RC5-29, RC5-32, and RC5-69, exhibited remarkable intracellular antibacterial activity, indicating their potential in treating infections.

Another significant patent involves the "Identification of a new ehrlichia species from a patient suffering from ehrlichiosis." Through this patent, Anderson and his team identified a new isolate of Ehrlichia species, which demonstrated distinct variations from previously known isolates. This patent also includes the development of a diagnostic kit and associated methods for detecting ehrlichiosis in humans, as well as screening for drugs that may be toxic to the new isolate.

Career Highlights

Throughout his career, Burt E Anderson has collaborated with notable institutions, including the Department of Health of the United States of America. His innovative solutions have contributed to scientific advancements and improved public health outcomes.

Collaborations

Anderson has worked alongside esteemed colleagues, including Russell L Regnery and Jacqueline E Dawson, further enriching the collaborative landscape of his research endeavors. Their collective expertise has facilitated significant advancements in the development of therapeutic interventions for infectious diseases.

Conclusion

Burt E Anderson stands out as a remarkable inventor whose work has the potential to influence the fields of microbiology and medicine. His ten patents reflect a dedication to addressing critical health issues through innovative research and development, positioning him as a key player in the ongoing fight against bacterial infections.